News Chart CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-14 EDT			5-day change	1st Jan Change
1.94 ^USD	+2.65%		-52.33%	+25.16%

05-09	BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating	MT
05-09	Wedbush Upgrades CytomX Therapeutics to Outperform From Neutral, Adjusts Price Target to $8 From $3	MT

4058a85bcef456cb4c9da8.NeOz2gheFr8Qr_WCCrGZCW5KO9RTjpPmUuG0fNPNgIY.QY_xmWomWfE9-rq0cNOteVozAp0mz_-AHLncJeX1tM9Qr8WZMGls0Sn3kg~7d4c4a450e4480fff542a92e9c05f026